To determine texture features of IDC and invasive lobular carcinoma (ILC) of the breast on full-fi eld digital mammography (FFDM). To evaluate the ability of texture analysis to diff erentiate between those tumor types. Materials and methods Fourteen IDC and nine ILC imaged with FFDM were included in this study. For each lesion the ROI was manually defi ned covering the lesion and 1 cm normal-appearing breast tissue around the lesion. Texture features derived from the grey-level histogram, the co-occurrence matrix, the run-length matrix, the absolute gradient, the autoregressive model, and the wavelet transform were calculated for the ROIs. Fisher coeffi cients were calculated to determine which texture features were bestsuited for distinguishing between IDC and ILC. Based on the combination of those fi ve texture features with the highest Fisher coeffi cients, lesion classifi cation was performed, using linear discriminant analysis (LDA) and principal component analysis (PCA) classifi ers, as well as a k-means clustering algorithm. Classifi cation accuracy was used as the primary outcome measure. Results Of the fi ve texture features with the highest Fisher coeffi cients, the top four were derived from the wavelet transform. Using LDA and PCA, classifi cation accuracies of 82.6% (19 of 23 lesions) and 78.3% (18 of 23 lesions) were achieved, respectively. k-means clustering also yielded a similar classifi cation accuracy of 82.6% (19 of 23 lesions). Conclusions Texture features, best suited for discrimination between ILC and IDC, are derived from the wavelet transform. Texture analysis of breast cancer cases imaged with FFDM allows a good degree of accuracy of discrimination between IDC and ILC.
Introduction ShearWave™ elastography (SWE) provides a quantitative measure ment of tissue stiff ness with high spatial resolution and may improve characterization of breast masses. The goal of this study was to evaluate the reproducibility of SWE and the impact of adding SWE features to the BI-RADS classifi cation of breast masses from the fi rst 1,000 cases in a prospective multicenter trial. Methods SWE studies were performed on a prototype of the Aixplorer system (Supersonic Imagine, Aix-en-Provence, France). A subset of 192 breast lesions (42.71% malignant) was analyzed. Reproducibility of SWE images and measurements was assessed; logistic regression analysis was performed to predict the pathology fi ndings. SWE features were added to the ultrasound BI-RADS to generate models that were challenged by comparing the areas under the ROC curves (Az), and the sensitivity and specifi city scores. Results In the preliminary analysis, intra-operator reproducibility of SWE size (R ≥0.93) and mean elasticity (R = 0.88) measurements were in near-perfect agreement. Using the best three-variable model (BIRADS + elasticity shape + maximum elasticity), the Az increased from 0.77 to 0.93 and specifi city increased from 61.8% to 87.3%, although sensitivity decreased from 92.7% to 87.8%. Adding more variables did not eff ect further improvements. Conclusions In this ongoing study, SWE provided reproducible information (elasticity values and SWE mapping) that improved the characterization of breast lesions. These features are directly linked to the characteristics of SWE: local quantifi cation and millimeter resolution. Further evaluation of the study is in progress. Introduction Macrolane™ volume restoration factor (VRF) (Q-Med) is in vogue for use in breast augmentation. There is sparse literature on the imaging characteristics of complications resulting from Macrolane™ injection. Methods This study describes the multimodality imaging of 12 patients from three centres who had breast complications as a result of Macrolane™ injection. The patients had all undergone Macrolane™ injection at varying intervals prior to presentation. Macrolane™ consists of non-animal stabilised hyaluronic acid (NASHA™) and is approved for nonsurgical breast augmentation. Treatment involves injection of up to 100 ml fl uid, superfi cial to the pectoral muscle and deep to the glandular breast disc, and is semipermanent, usually only lasting up to 1 year before a top-up injection is required. Results Presenting symptoms included breast lumps, breast pain and axillary pain. The complications seen on imaging included abscess formation, indeterminate masses, subpectoral collections and complex cystic collections. The fl uid and indeterminate masses were not all resorbed in the timeframe expected of Macrolane™ and remained in situ in some cases for at least 2 years. Conclusions Macrolane™ injection is associated with long-term complications and creates diagnostic challenges on breast imaging that are only beginning to emerge in the breast clinics and that may warrant triple assessment.
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